Dulaglutide, liraglutide and subcutaneous semaglutide have been approved for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus with established cardiovascular disease, dulaglutide is approved for use in type 2 diabetes mellitus with multiple risk factors, and both liraglutide and semaglutide have been approved for chronic weight management
But at the same time, research shows GLP-1s may improve wound healing, reduce psoriasis inflammation, and potentially help other skin conditions
Tirzepatide Weight Loss Mechanism Explained Looking for a deeper understanding of Tirzepatide, the new weight loss medication making waves
Thats why regular exercise, especially resistance training, which builds muscle mass, should be considered an essential component of weight management with GLP-1s
In other words, roughly two-thirds of every kilogram lost was fat, not muscle
It plays a role in how our brain processes rewards, which is closely tied to our mood and motivation